Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $24.5M | $16.4M | $39.1M | $47.4M | $4.9M | $3.3M | $643.0K | $401.0K |
| Cost of revenue | $8.2M | $6.8M | $10.1M | $38.0M | $2.8M | $2.0M | $0 | $0 |
| Gross profit | $16.3M | $9.6M | $29.0M | $9.4M | $2.1M | $1.3M | $643.0K | $401.0K |
| Gross margin | 66.5% | 58.8% | 74.1% | 19.8% | 43.7% | 38.7% | 100.0% | 100.0% |
| R&D | $50.3M | $88.1M | $100.4M | $91.7M | $75.1M | $56.8M | $18.3M | $15.3M |
| Operating income | −$50.1M | −$107.4M | −$123.0M | −$113.5M | −$210.6M | −$94.3M | −$49.6M | −$33.0M |
| EBITDA | −$47.7M | −$104.1M | −$118.5M | −$108.1M | −$200.7M | −$105.2M | −$45.2M | −$31.9M |
| Net income | −$51.0M | −$100.8M | −$109.7M | −$195.4M | −$234.2M | −$122.1M | −$45.1M | −$28.9M |
| Net margin | -207.7% | -615.0% | -280.5% | -412.4% | -4776.2% | -3682.2% | -7008.2% | -7211.0% |
| EPS (diluted) | -892.74 | -1684.64 | -1378.53 | -2359.49 | -145.82 | -49.97 | -14.94 | -9.32 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds LMNL.
No tracked institution reports a position in LMNL as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-02-01 | 1-for-10reverse |
No one on the platform has traded LMNL yet.
| $28M |
| — |
| IRDOpus Genetics, Inc. | $4.06 | +1.50% | $335M | — |
| LSBLakeShore Biopharma Co., Ltd | $0.63 | +0.00% | $26M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$LMNL What happened with our stocks? Will it trading?
View on StockTwits ↗$LMNL LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP https://www.stocktitan.net/news/LMNL/liminal-biosciences-announces-completion-of-the-plan-of-arrangement-1i158xlj6yuo.html
View on StockTwits ↗$LMNL: LIMINAL BIOSCIENCES VERKRIJGT GERECHTELIJKE TOESTEMMING VOOR OVERNAMEPLAN DOOR STRUCTURED ALPHA LP https://www.chartmill.com/stock/quote/LMNL/news?utm_source=prnews-2023-9-21-liminal-biosciences-verkrijgt-gerechtelijke-toestemming-voor-overnameplan-door-structured-alpha-lp&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗$LMNL where is the blathering dolt to tell us there is still time for clinical news run up of 3 cents before curtains?!
View on StockTwits ↗$LMNL: LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP https://www.chartmill.com/stock/quote/LMNL/news?utm_source=prnews-2023-9-19-liminal-biosciences-receives-final-court-order-for-plan-of-arrangement-with-structured-alpha-lp&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗$LMNL LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP https://www.stocktitan.net/news/LMNL/liminal-biosciences-receives-final-court-order-for-plan-of-mn4dcve1ws7c.html
View on StockTwits ↗$LMNL: LES ACTIONNAIRES DE LIMINAL BIOSCIENCES APPROUVENT LE PLAN D'ARRANGEMENT AVEC STRUCTURED ALPHA LP https://www.chartmill.com/stock/quote/LMNL/news?utm_source=prnews-2023-9-18-les-actionnaires-de-liminal-biosciences-approuvent-le-plan-darrangement-avec-structured-alpha-lp&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗$LMNL Should be a done deal by Tuesday with court clearance. Arrangement expected to close on or about September 30, 2023. Can this run up a bit in the meantime. I have seen this before when holders believe a takeover offer is low ball. Let’s see
View on StockTwits ↗$LMNL LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP https://www.stocktitan.net/news/LMNL/liminal-biosciences-shareholders-approve-plan-of-arrangement-with-fua5u5vbehh4.html
View on StockTwits ↗$LMNL: LIMINAL BIOSCIENCES DIENT GEWIJZIGD SCHEDULE 13E-3 EN AANVULLING IN OP DE CIRCULAIRE MET MANAGEMENTINFORMATIE https://www.chartmill.com/stock/quote/LMNL/news?utm_source=prnews-2023-9-13-liminal-biosciences-dient-gewijzigd-schedule-13e-3-en-aanvulling-in-op-de-circulaire-met-managementinformatie&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗$LMNL Release some positive clinical updates this week… that would be a great boost for valuation
View on StockTwits ↗$LMNL: LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR https://www.chartmill.com/stock/quote/LMNL/news?utm_source=prnews-2023-9-12-liminal-biosciences-files-amended-schedule-13e-3-and-supplement-to-the-management-information-circular&utm_medium=stocktwits&utm_campaign=pressRelease
View on StockTwits ↗$LMNL LIMINAL BIOSCIENCES FILES AMENDED SCHEDULE 13E-3 AND SUPPLEMENT TO THE MANAGEMENT INFORMATION CIRCULAR https://www.stocktitan.net/news/LMNL/liminal-biosciences-files-amended-schedule-13e-3-and-supplement-to-33xtr9fwwtjb.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.